BioCentury | Aug 28, 2020
Deals

BARDA enlisting start-ups in fight against COVID-19 via JLABS collaboration

...of SARS-CoV-2 virus in patients’ lungs.San Francisco-based Epic...
BioCentury | Jun 26, 2020
Product Development

21st century pandemic, prehistoric clinical trials

...do so quickly. The major providers of electronic health records, such as a Cerner and Epic...
BioCentury | Nov 16, 2019
Regulation

Stephen Hahn’s road to White Oak

...campaign to prevent genetically modified salmon from reaching American grocery store shelves. Recovering from an Epic...
...Hahn accomplished his principal mission, leading the institution’s recovery from a disastrous transition to the Epic...
BioCentury | Sep 21, 2019
Politics, Policy & Law

Congress won’t adopt Pelosi’s price controls, but it may revamp Medicare Part D

...avidity for partisan antagonism in Washington could cause attempts on agreement to collapse in an epic...
BioCentury | Aug 2, 2019
Regulation

Digital platforms that could make real-world data usable

...resulted in “increases of efficiency, data quality and timeliness.” REDCap is connecting directly to local EPIC...
...record systems to allow data flow to proceed in real-time. Twenty-four academic institutions that use EPIC...
BioCentury | Jul 15, 2019
Financial News

AI play Recursion raises $121M to expand into new drug discovery

...investors, including Lux Capital, Data Collective, Mubadala Ventures, Two Sigma Ventures, Obvious Ventures, Felicis Ventures, Epic...
BioCentury | Jul 10, 2019
Clinical News

July 10 Clinical Quick Takes: Darzalex quad combo raises MM complete response, plus Geneos and ViiV

...has become the first to receive a DNA-based neoantigen-targeting vaccine. The vaccine, designed with Geneos' GT-EPIC...
BioCentury | May 22, 2019
Company News

Management tracks: Gottlieb re-joining NEA; plus Seattle Genetics, Celsius and more

...Ltd. (Cambridge, U.K.) and Foster was portfolio manager at Meltwind Advisory LLP. Cancer diagnostic company Epic...
...Wong, Staff Writer, and Steve Usdin, Washington Editor Akrevia Therapeutics LLC Cell Mogrify Ltd. Celsius Therapeutics DNAnexus Inc. Eiger BioPharmaceuticals Inc. Epic...
BioCentury | Apr 22, 2019
Company News

Management tracks: MeiraGTx, Retrophin, Aduro

...DeWildt to chief commercial officer from SVP of commercial and market access. Cancer diagnostic company Epic...
...Transmembrane protein 173; TNFSF13 (APRIL) - Tumor necrosis factor ligand superfamily member 13 BioCentury Staff Aduro Biotech Epic...
BioCentury | Mar 27, 2019
Company News

Management tracks: Epic, Axcella, KalVista

...Lloyd Sanders will succeed Murali Prahalad as president and CEO of cancer diagnostic company Epic Sciences...
...Myriad Genetics Inc. (NASDAQ:MYGN). Prahalad, who has stepped down to pursue other opportunities, will join Epic’s...
...N.J.). He succeeds interim CEO Shenda Baker, who remains CSO and a director. BioCentury Staff Axcella Health Inc. Epic...
Items per page:
1 - 10 of 186
BioCentury | Aug 28, 2020
Deals

BARDA enlisting start-ups in fight against COVID-19 via JLABS collaboration

...of SARS-CoV-2 virus in patients’ lungs.San Francisco-based Epic...
BioCentury | Jun 26, 2020
Product Development

21st century pandemic, prehistoric clinical trials

...do so quickly. The major providers of electronic health records, such as a Cerner and Epic...
BioCentury | Nov 16, 2019
Regulation

Stephen Hahn’s road to White Oak

...campaign to prevent genetically modified salmon from reaching American grocery store shelves. Recovering from an Epic...
...Hahn accomplished his principal mission, leading the institution’s recovery from a disastrous transition to the Epic...
BioCentury | Sep 21, 2019
Politics, Policy & Law

Congress won’t adopt Pelosi’s price controls, but it may revamp Medicare Part D

...avidity for partisan antagonism in Washington could cause attempts on agreement to collapse in an epic...
BioCentury | Aug 2, 2019
Regulation

Digital platforms that could make real-world data usable

...resulted in “increases of efficiency, data quality and timeliness.” REDCap is connecting directly to local EPIC...
...record systems to allow data flow to proceed in real-time. Twenty-four academic institutions that use EPIC...
BioCentury | Jul 15, 2019
Financial News

AI play Recursion raises $121M to expand into new drug discovery

...investors, including Lux Capital, Data Collective, Mubadala Ventures, Two Sigma Ventures, Obvious Ventures, Felicis Ventures, Epic...
BioCentury | Jul 10, 2019
Clinical News

July 10 Clinical Quick Takes: Darzalex quad combo raises MM complete response, plus Geneos and ViiV

...has become the first to receive a DNA-based neoantigen-targeting vaccine. The vaccine, designed with Geneos' GT-EPIC...
BioCentury | May 22, 2019
Company News

Management tracks: Gottlieb re-joining NEA; plus Seattle Genetics, Celsius and more

...Ltd. (Cambridge, U.K.) and Foster was portfolio manager at Meltwind Advisory LLP. Cancer diagnostic company Epic...
...Wong, Staff Writer, and Steve Usdin, Washington Editor Akrevia Therapeutics LLC Cell Mogrify Ltd. Celsius Therapeutics DNAnexus Inc. Eiger BioPharmaceuticals Inc. Epic...
BioCentury | Apr 22, 2019
Company News

Management tracks: MeiraGTx, Retrophin, Aduro

...DeWildt to chief commercial officer from SVP of commercial and market access. Cancer diagnostic company Epic...
...Transmembrane protein 173; TNFSF13 (APRIL) - Tumor necrosis factor ligand superfamily member 13 BioCentury Staff Aduro Biotech Epic...
BioCentury | Mar 27, 2019
Company News

Management tracks: Epic, Axcella, KalVista

...Lloyd Sanders will succeed Murali Prahalad as president and CEO of cancer diagnostic company Epic Sciences...
...Myriad Genetics Inc. (NASDAQ:MYGN). Prahalad, who has stepped down to pursue other opportunities, will join Epic’s...
...N.J.). He succeeds interim CEO Shenda Baker, who remains CSO and a director. BioCentury Staff Axcella Health Inc. Epic...
Items per page:
1 - 10 of 186